Close

Russia’s Sputnik V likely to be available for supply from January

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Novo Nordisk and AWS Enter Strategic AI Partnership to Accelerate Drug Discovery

Novo Nordisk has announced a strategic partnership with Amazon...

Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals

The Trump administration is preparing to announce a new...

Huawei Expands AI Drug Discovery Ambitions Amid Domestic Chip Push and Policy Support

Huawei intends to deepen its artificial intelligence partnerships with...
- Advertisement -

Russia’s Sputnik-V COVID-19 vaccine might become available for supply as early as next month, the country’s sovereign wealth fund RDIF’s top official told ThePrint.

According to Kirill Dmitriev, the Chief Operating Officer (COO) of RDIF, they are hoping for approval in January 2021, and are “ready to supply the vaccine to a wider population within the same timeframe”.

“As we understand, the country’s government is working on a special Covid-19 inoculation programme that would be using the processes, technology and network of the Universal Immunisation Programme (UIP) currently in place,” Dmitriev said while talking about the distribution process of the vaccine once it receives approval.

“Strengthening the cold chain systems and deploying trained personnel to ensure vaccine safety would be key to the inoculation process’s ultimate success. Another important thing would be to prioritise socio-demographic groups that would be among the first to gain access to the vaccine apart from healthcare professionals,” he added.

 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Novo Nordisk and AWS Enter Strategic AI Partnership to Accelerate Drug Discovery

Novo Nordisk has announced a strategic partnership with Amazon...

Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals

The Trump administration is preparing to announce a new...

Huawei Expands AI Drug Discovery Ambitions Amid Domestic Chip Push and Policy Support

Huawei intends to deepen its artificial intelligence partnerships with...

McKesson to Acquire Precision Medicine Group for $2.25 Billion

US-based healthcare services provider McKesson has agreed to acquire...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »